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Amajor goal of modern protein chemistry is to create
new proteins with different functions. One approach
is to amalgamate secondary and tertiary structures
from different proteins. This is difficult for several
reasons, not the least of which is the fact that the
junctions between secondary and tertiary structures
are not degenerate and usually affect the function
and folding of the entire complex. Here, we offer a so-
lution to this problem by coupling a large combinato-
rial library of about 107 different N- and C-terminal
junctions to a powerful system that selects for func-
tion. Using this approach, the entire Leptin and folli-
cle-stimulating hormone (FSH) were inserted into an
antibody. Complexes with full retention of function
in vivo and in vitro, although rare, were found easily
by using an autocrine selection system to search
for hormonal activity. Such large diversity systems,
when coupled to robust selection systems, should
enable construction of novel therapeutic proteins.
INTRODUCTION
Structurally, a protein can be considered to be an ensemble of
secondary and tertiary folds connected to each other by
N- and C-terminal junctions (Gerstein et al., 1994; Pritchard
et al., 2003). Sometimes these junctions are simple extended
polypeptide chains, whereas in other cases they are part of a
more complicated secondary structure. Because of advances
in protein structure determination, we have a large and ever-
growing menu of secondary and tertiary folds in proteins.
Thus, in principle, one should be able to construct new pro-
teins by inserting some of these secondary structure elements1134 Chemistry & Biology 22, 1134–1143, August 20, 2015 ª2015 El(guests) into a new protein partner (host). Indeed, in early pio-
neering studies, different guests have been successfully inserted
into host proteins, including short peptides and cytochrome b562
into b-lactamase (Edwards et al., 2008; Mathonet et al., 2006),
b-lactamase into maltodextrin-binding protein (Betton et al.,
1997), calmodulin into GFP (Baird et al., 1999), 1,4-b-xylanase
into 1,3-1,4-b-glucanase (Ay et al., 1998), and, most recently,
different hormones into bovine and humanized antibodies (Liu
et al., 2015; Zhang et al., 2015; Zhang et al., 2013b; Zhang
et al., 2013c). However, these studies were design based,
whereas here we present a selection-based method that is argu-
ably much more powerful and general. There were two main
problems to be solved in the generation of a method based on
selection. The most widely appreciated problem is that function
often requires approximation in three dimensions of an array of
secondary structure elements. A less appreciated, but perhaps
more critical constraint, is that the junctions between secondary
structures likely represent a distinct structural element that en-
ables proper folding of the secondary structures to which they
are appended. Indeed, recent studies have shown that some
of these junctions (b/b, a/b, and b/amotifs) may function accord-
ing to a defined set of rules (Balasco et al., 2013; Koga et al.,
2012).
The problem of defining the functional requirements of junc-
tion sequences can be separated into two parts: (1) to experi-
mentally generate a large number of random junctions, and
(2) to test which junctions can act in concert with guests to
enable function. In principle, the first problem can be ap-
proached experimentally using modern combinatorial library
methods. Thus secondary structural elements, either singly or
in combination, can be linked to the protein scaffold by an arbi-
trarily large number of different N- and C-terminal junctions so as
to assemble new tertiary structures. To solve the selection
problem, the junctions that are permissive for function can be
selected using autocrine-based screenings. In such autocrine
selection systems, millions of potential agonists and their re-
ceptor are expressed in cells such that all cells have the samesevier Ltd All rights reserved
Figure 1. Overall Structures of Guest Molecules
(A) Cartoon representation of human Leptin (PDB: 1AXB) (Zhang et al., 1997).
(B) Cartoon representation of human FSH (PDB: 4AY9) (Jiang et al., 2012).
(C) Cartoon representation of the scFSH. The polypeptide (GSGSNATGSGS
NATSGSTS) linking the C terminus of the FSH b chain and N terminus of the
FSH a chain is indicated by a gray dashed line.cognate receptor while each individual cell expresses only a
single unique member of the large repertoire of potential ago-
nists. When combined with modern cell sorting, one can use
this approach to explore a large repertoire of combinatorial junc-
tions by inserting a known protein guest agonist in frame into a
protein host, such as an antibody, where the guest is separated
from the host on either side by random amino acid sequences
that may function as permissive junctions. Functional autocrine
selection allows determination of which junctions allow proper
folding and function of the guest.
As proof of concept, the goal of the present experiment was
to test the central idea that if a very large number of different
junctions can be tested, we could select those were permissive
for proper function of the guest, even if they were rare. We
studied whether antibodies could be used as hosts into which
hormones could be introduced as guests. The variable amino
acids of the complementarity determining region (CDR) H3
loop of an antibody were replaced by two sets of 8–18 amino
acids (potential N- and C-terminal junction sequences) between
which were cloned the entire 146 and 203 amino acids of
the hormones human Leptin and human follicle-stimulating
hormone (FSH), respectively. Since it was our intention to
investigate a very large number of candidates, the key was
to construct a robust system for selection of permissive junc-
tions. Thus, we coupled high junctional diversity to autocrine-
based phenotypic screens to select for those junctions that
allow function of the embedded Leptin and FSH proteins.
Sequencing of the clones that retained agonist activity allowed
us to characterize those junctions that permitted proper guest
function from a combinatorial diversity system of 3 3 107
different members. Only about 0.06% and about 0.18% mem-
bers were permissive for function of Leptin and FSH, respec-
tively, and the permissive sequences were different for the
two guests.
These constructs allowed us to study critical biological
issues. Because the embedded Leptin is too large to cross
the blood-brain barrier (BBB), the generation of embeddedChemistry & Biology 22, 1134–Leptin enabled an analysis of the relative contributions of Leptin
signaling at circumventricular organs (CVOs) versus brain
parenchyma.
The methods described here also provide a starting point for
the generation of new proteins in which the embedded probe
can report on proper folding. In this case, the role of the guest
is simply to report on proper folding of the complex as a func-
tion of changes made elsewhere. When combined with current
computational methods (Balasco et al., 2013; Koga et al.,
2012), these host-guest complexes could be a new tool to
address the protein-folding problem because they allow a
high-throughput analysis of a very large number of variant pro-
teins for those that fold properly. This changes the search for
proper folding from analysis of a bulk solution or limited number
of variants to an analysis of a very large number of single mole-
cules. Also, one does not rely on an intrinsic function of the host
that could be perturbed by substitutions even if they are some
distance from the active site, thereby confusing the analysis.
Finally, this method should help in the generation of new protein
therapeutics with distinct properties.
RESULTS
Choice of Guest Molecules
To determine whether the combinatorial process of inserting
guests into protein hosts could be general, we studied two
very different protein hormones, Leptin and FSH. Because the
two hormones have very different structures, their choice allows
analysis of whether the method is general as opposed to being
limited to only certain folds. As Leptin is folded into a compact
four-helix bundle (Figure 1A) (Zhang et al., 1997), one might
predict that the favorable binding energy of the helices for
each other would make selection of junctions less critical. How-
ever, this same rigidity of the guest could interfere with the
folding of the entire host-guest complex. FSH folds mostly
into b-sheet structures, and is composed of a and b subunits
with central cysteine-knot motifs from which three b hairpins
extend (Figure 1B) (Jiang et al., 2012). In terms of these exper-
iments, the heterodimer assembly may pose a special problem.
If the FSH subunits are treated individually the process be-
comes a four-linker combinatorial problem, whereas if the
monomeric subunits of the heterodimer are covalently linked,
the number of linkers is reduced to three; one on either end
and one in the middle. Thus, we set out to construct a single-
chain FSH (scFSH) by linking the a and b subunits using a
GSGSNATGSGSNATSGSTS peptide linker that is permissive
for heterodimer formation (Figure 1C) (Trousdale et al., 2007).
Indeed, the scFSH covalent dimer was shown to be functional
using a reporter cell line expressing the FSH receptor (see
below).
Construction of Combinatorial Junctions
Thehost is a randomly chosen antibody, scFv, fromour very large
human naive antibody library (Gao et al., 1997) with a CDR H3
containing 19 residues (Kabat numbering [Kabat et al., 1991])
(Figure 2A). To maintain proper folding of the antibody core while
maximizing the flexibility of junctions, most of the CDR H3 loop,
residues LH98GITKTSTCYTH100H (red), were replaced by mem-
bers of a combinatorial N- and C-terminal junction library1143, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1135
Figure 2. Construction of Combinatorial Junctions
(A) Cartoon representation of the homology model of the antibody scaffold,
which was constructed using Modeller (Sali and Blundell, 1993), with
structures of 1RZI, 3QOT, 4HJ0, 3NPS, 3G04, 3D69, and 4J4P as templates.
The heavy and light chains are colored in cyan and wheat, respectively. The
LH98GITKTSTCYTH100H segment in the CDR H3 loop, which was replaced to
generate the combinatorial junction library, is colored in red.
(B) Schematic demonstration of combinatorial junction design. The three-
residue random linker and one to three copies of GGGGS linker are indicated
with XXX and (GGGGS)1–3, respectively.designed to generate a highly diverse array of sequences that
attach the Leptin and scFSH guests to the antibody host. This
choice of site of insertion was based on examination of the ho-
mology model of the parental scaffold (Figure 2A) to determine
where a large insert can readily be accommodated: most of the
guest would extend into the solvent, with the rest expected to
pack against other CDRs of the antibody host.
To construct proteins with functional inserts, a GGGGS linker
and similar glycine-serine linkers have been commonly used
together with some other more rigid linkers. The GGGGS linker
provides tremendous flexibility and has been successfully used
in many cases. However, in some cases the GGGGS linker
might not the best in terms of protein expression, stability,
and extension of the guest. To generalize this method, based
on the structure model of antibody, we introduced a random
three-residue linker (denoted XXX) between the GGGGS linker
and the antibody scaffold to provide extra length and, more
importantly, the potential to optimize the linker for higher
expression, better stability, and greater extension of domains
of host and guest of selected clones (Klein et al., 2014; Reddy
Chichili et al., 2013; Silacci et al., 2014; Volkel et al., 2001).
The combinatorial junction library was designed to contain junc-
tions of an XXX linker (Figure 2B) and one to three copies of a
GGGGS linker denoted (GGGGS)1–3 at both the N and C termini
of Leptin and scFSH (Figure 2B). The total number of colonies in
the Leptin and scFSH libraries were 2.88 3 107 and 1.09 3 107,
respectively, for the combination of the N- and C-terminal li-
braries. While the theoretical diversity of the library is 9 3
109 different members, we carried out experiments to ensure1136 Chemistry & Biology 22, 1134–1143, August 20, 2015 ª2015 Elthat there is not an excessive repetition of only a few unique
clones. Thus, we sequenced 20 clones, and no antibody was
repeated.
Autocrine-Based Selection of Functional Junctions
Autocrine-based flow cytometry sorting of cells in which the
expression of b-lactamase reporter gene is induced by various
cell signaling responsive elements has been widely used
because of its high accuracy and sensitivity (Qureshi, 2007).
When b-lactamase is not expressed in the reporter cells loaded
with an engineered fluorescent substrate that covalently links
two fluoroprobes (coumarin and fluorescein), the substrate
remains intact, and thus excitation of the coumarin results in
fluorescence resonance energy transfer (FRET) to the fluores-
cein and emission of green fluorescence. When the expression
of b-lactamase is induced in the reporter cells the substrate is
cleaved, and excitation of the now free coumarin functionality
results in a blue fluorescence signal. The resulting ratio of blue
fluorescence signal to green fluorescence signal provides a
normalized measure of the reporter response. The sis-inducible
element (SIE) (Bendinelli et al., 2000) and the cyclic AMP-respon-
sive element (CRE) (Heindel et al., 1975) driven b-lactamase-
based reporter cell lines were constructed and tested for the
human Leptin receptor (LepR) (designated LepR SIE-Bla) and
the human FSH receptor (FSHR) (designated FSH CRE-Bla),
respectively (Figure 3). To isolate functional antibody clones,
FRET-based fluorescence-activated cell sorting (FACS) was
carried out using stringent gating (Figure 3). For LepR SIE-Bla
cells, there was significant enrichment after two rounds of sort-
ing, from only 0.06% positive cells (versus 66.9% positive cells
in positive control infected with Leptin lentivirus) in the first round
to 3.30% positive cells (versus 6.57% positive cells in positive
control infected with Leptin lentivirus) in the second round
(Figures 3F and 3G). The reason that the population of positive
cells in the positive control in the second round is less than
that in the first round is because we used less lentivirus input
to minimize transactivation by secreted antibodies. For FSH
CRE-Bla cells, one round of sorting yielded 0.18% positive cells
(Figure 3H). After each round of sorting, antibody gene fragments
were recovered by the PCR using cell lysates as templates, and
re-inserted into the lentiviral vector for the next round of sorting
and/or clone screening of the clones as necessary. Twenty
clones were picked from the second round for LepR SIE-
Bla cells, and the first round for FSHR CRE-Bla cells. Plas-
mids were extracted from these clones and transfected into
HEK293T cells to express secreted antibodies. Supernatants
were isolated 2 days after transfection and tested to identify
clones with agonist activity. Six clones out of 20 were found to
be capable of activating LepR SIE-Bla cells, while 3 out of 20
clones were able to activate FSHR CRE-Bla cells. These clones
were sequenced. The sequences of permissive junctions were
analyzed (Table 1). For scFSH, clone B (Figure S1A) was the
most potent. In addition, the sequences of non-permissive junc-
tions that showed no activity in the FRET assay were analyzed
(Tables S1 and S2; Figures S1C and S1D). Possible reasons
why there were still negative clones in the sorted pool include
stimulation of close neighboring cells by secreted antibody
(these transactivated clones would not contain the active anti-
body genes), mutation in the PCR reaction when recoveringsevier Ltd All rights reserved
Figure 3. Construction of Autocrine-Based
Stable Cell Lines and Autocrine Selection of
Functional Junctions
(A) Schematic diagram of elements used for auto-
crine cell construction of LepR SIE-Bla cells. Once
LepR on the surface of the LepR SIE-Bla cells is
stimulated upon binding of agonist, the downstream
SIE signaling pathway is turned on and the cells
start to express b-lactamase, which can then cleave
the LiveBLAzer-FRET B/G substrate (CCF4-AM) and
change the FRET signal.
(B) Expression of HA-tagged LepR in LepR SIE-Bla
cells. One million of the parental SIE-Bla cells and
LepR SIE-Bla cells were lysed in 100 ml of 13 SDS-
PAGE loading buffer. The expression of HA-tagged
LepR was detected with a-HA antibody.
(C) Response of LepR SIE-Bla cells to 1 ng/ml Leptin.
(D) Schematic diagram of elements used for auto-
crine cell construction of FSHR CRE-Bla cells.
(E) Response of FSHR CRE-Bla cells to 1 ng/ml FSH.
(F and G) First and second round of sorting for
Leptin activity. The negative and positive controls for
sorting are non-infected LepR SIE-Bla cells and
LepR SIE-Bla cells infected with Leptin lentiviruses,
respectively. Cells with the highest fluorescence ratio
in the Pacific Blue channel to the AmCyan channel
were collected using aMoFlo Astrios FlowCytometry
Sorter.
(H) One-round sorting for FSH activity. The negative
and positive controls for sorting are non-infected
FSHR CRE-Bla cells and FSHR CRE-Bla cells
infected with scFSH lentiviruses, respectively. The
x axis is the green signal of uncleaved substrate and
the y axis is the blue signal of substrate after cleav-
age by b-lactamase.
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Table 1. Sequences of Active Clones
Clones N Linker C Linker
Active Clones for LepR
A HLTGGGGS GSGGSGGGGSDPS
B PWAGGGGSGGGGSGGGGS GGGGSQPP
C LGVGGGGS GGGGSERT
D KTSGGGGSGGGGS GGGGSSDE
E LGVGGGGS GGGGSERT
F KVTGGGGS GGGGSQLE
Active Clones for FSHR
A RSHGGGGS GGGGSVNP
B QRVGGGGS GGGGSGGGGSRSA
C RVLGGGGS GGGGSGGGGSQSSthe gene from the lysates of sorted cells, and recombination or
deletion of DNA in cells.
Improved Selection of Junctions
While the first selection yielded functional proteins, the yield of
the host-guest proteins was not optimal. To improve protein
production, another selection was carried out whereby a protein
yield parameter was incorporated. To accomplish this, a new
vector was used in which the gene encoding mCherry was
fused to the C terminus of the scFv gene (Shaner et al., 2004).
This allowed selection for high-expressing clones by using an
additional gate for a high mCherry signal prior to the FRET
gate. Three libraries were studied. One was the original library.
In the other two libraries, either the N- or the C-terminal linkers
identified in the previous experiment were held constant and
the other linkers comprised the same random sequences that
were used previously. For Leptin, these studies yielded a new
clone (clone 2 in Figure S1B) with an RHMGGGGS at the N ter-
minus and GGGGSGGGGSTDT at the C terminus. This protein
expressed much better than the previously selected clone 1
with LGVGGGGS at the N terminus andGGGGSERT at the C ter-
minus while still retaining full Leptin activity (Figure S1B).
The most active scFv clone of the antibody containing the
Leptin guest with the highest yield was converted to a Fab format
(Fab-Leptin) or full immunoglobulin G (IgG) format (IgG-Leptin).
The unaltered host, Fab-Leptin, and IgG-Leptin were cloned in
pFUSE-based vectors (InvivoGen) and expressed in FreeStyle
293-F cells (Life Technologies). After a one-step affinity purifi-
cation, all antibodies were purified to 95% (Figure S2). The
production yield was 6–10 mg from 1 l of cell culture for all
antibodies.
In Vitro Activity
Circular dichroism (CD) spectroscopy (Greenfield, 2006) and dif-
ferential amide hydrogen-deuterium exchange mass spectrom-
etry (HDX-MS) (Chalmers et al., 2011; Pascal et al., 2012) studies
showed that the antibody scaffold folded properly after the
insertion of Leptin and that the embedded Leptin in the antibody
scaffold was essentially the same as the native Leptin (see Sup-
plemental Information and Figure S3). The activity of purified
host-guest complexes for the LepR was tested in two different
assays. First, the FRET assay using the b-lactamase-based1138 Chemistry & Biology 22, 1134–1143, August 20, 2015 ª2015 ElLepR SIE-Bla cell line was used. The half-maximal effective con-
centration (EC50) of Fab-Leptin, IgG-Leptin, and native Leptin
were 118.3 ± 17.2, 59.7 ± 21.2, and 313.4 ± 27.7 pM, respectively
(Figure 4A). The activity of native Leptin was similar to values
reported in the literature, EC50 of420–550 pM,while the activity
of Fab-Leptin and IgG-Leptin were significantly higher (Ceccarini
et al., 2009). We also used an orthogonal proliferation assay
using aBaf3 LepR cell line, which is dependent on Leptin or inter-
leukin-3 for survival. The activity was similar to that measured
using the FRET assay: EC50 of 131.9 ± 6.5 pM for Fab-Leptin,
37.2 ± 3.9 pM for IgG-Leptin, and 309.6 ± 3.7 pM for native Lep-
tin (Figure 4B).
The most active scFSH clone was converted to IgG-scFSH as
for IgG-Leptin, and also cloned into the pFUSE-based vector
and produced as for IgG-scFSH. Highly pure scFSH and IgG-
scFSH were obtained after one-step affinity purification (Fig-
ure S2). The EC50 of IgG-scFSH, scFSH, and native FSH were
5.5 ± 0.5, 5.7 ± 0.5, and 4.6 ± 0.5 pM, respectively (Figure 4C)
in a FRET assay using the b-lactamase-based FSHR CRE-Bla
cell line.
In Vivo Activity
We selected the Leptin construct for comprehensive in vivo
studies because, rather than simply confirming the in vitro
studies, we could also address some critical issues in the field.
Initially we showed that, similar to Leptin, IgG-Leptin is stable
at core body temperature, making it possible to administer it
chronically. Moreover, since antibodies generally exhibit a long
half-life in circulation, we reasoned that embedding Leptin into
the antibody scaffold might increase the half-life of the hormone,
which is normally rapidly cleared by the kidneys and other pe-
ripheral organs (Ceccarini et al., 2009). Indeed, IgG-Leptin had
a significantly increased half-life in plasma, with over 50% of
the protein remaining at 4 hr after administration (Figure 5A).
This decreased clearance is likely a result of the fact that the
embedded Leptin is 187.2 kDa, which is greater than the exclu-
sion limit for glomerular filtration (Ceccarini et al., 2009).
We next tested the bioactivity of IgG-Leptin in vivo whereby
the studies were designed to assess the relative contributions
of Leptin action on either side of the BBB. Leptin can act on neu-
rons that project dendrites to CVOs in the median eminence in
front of the BBB and can also cross the BBB at these sites after
uptake by tanycytes and transport to the cerebrospinal fluid (Bal-
land et al., 2014; Langlet et al., 2013). Because the embedded
Leptin is of a larger size than the exclusion limit for uptake at
CVOs, any effects of the embedded Leptin would by necessity
be a result of effects in front of the BBB. Thus, we were able to
assess efficiently the relative importance of Leptin action at
CVOs versus brain parenchyma. We first compared neuronal
activation in the hypothalamus in response to central treatment
with IgG-Leptin versus native Leptin. IgG-Leptin was injected in-
tracerebroventricularly (i.c.v.) by delivering the protein directly
into the ventricles. Robust phosphorylation of STAT3 in multiple
regions in the hypothalamus was observed. STAT3 activation in
neurons adjacent to the ventricles was comparable with that
observed with the i.c.v. injection of an equal molar amount of
Leptin, consistent with the in vitro data that IgG-Leptin can acti-
vate signal transduction with similar or even greater efficacy than
native Leptin (Figure 5B). Somewhat lower levels of STAT3sevier Ltd All rights reserved
Figure 4. In Vitro Activity
(A) FRET assay using LepR SIE-Bla cells to measure the Leptin EC50 of the
selected embedded Leptin clone. The EC50 of Fab, IgG, and native Leptin were
118.3 ± 17.2, 59.7 ± 21.2, and 313.4 ± 27.7 pM, respectively.
(B) Proliferation assay using Baf3 LepR cells to measure the EC50 of the
selected embedded Leptin clone. The EC50 of Fab, IgG, and native Leptin were
131.9 ± 6.5, 37.2 ± 3.9, and 309.6 ± 3.7 pM, respectively.
(C) FRET assay using FSHR CRE-Bla cells to measure EC50 of FSH in the
selected embedded FSH clone. The EC50 of IgG-scFSH, scFSH, and native
FSH were 5.5 ± 0.5, 5.7 ± 0.5, and 4.6 ± 0.5 pM, respectively.
All data are plotted as means ± SEM (error bars).activation were noted at some sites distant from the ventricle,
suggesting that the rate of diffusion of IgG-Leptin through the tis-
sue might be reduced. While similar levels of STAT3 activation
were seen after i.c.v. administration (Kastin and Pan, 2000), pe-
ripheral administration of Leptin resulted in a different pattern of
STAT3 phosphorylation versus wild-type Leptin, was confined to
the neurons in the arcuate nucleus (ARC), and was otherwise ab-
sent from other neuronal populations in the hypothalamus that
were activated by peripheral infusion of native Leptin and central
administration of IgG-Leptin. These data suggest that peripher-Chemistry & Biology 22, 1134–ally administered IgG-Leptin can activate dendrites from ARC
neurons that project to the median eminence but cannot
cross the BBB and activate other populations. Both pro-opiome-
lanocortin and neuropeptide Y/agouti-related protein neurons
in the ARC are known to project in close proximity to the me-
dian eminence and can directly sense circulating molecules in
plasma, and are thus able to modulate neural activity without
transport across the BBB (Morita and Miyata, 2013; Mullier
et al., 2010).
We next examined whether activation of the ARC neurons by
IgG-Leptin was sufficient to elicit a metabolic effect by infusing
IgG-Leptin and native Leptin into obese mice via subcutaneous
osmotic pumps. While IgG-Leptin significantly reduced food
intake aswell as bodyweight following the administration, the ef-
fect was 50% lower than that of native Leptin (Figure 5C, left).
Similarly, the ability of IgG-Leptin to decrease food intake, body
weight, and fat composition in wild-type mice was reduced (Fig-
ure 5C, middle). Thus despite the fact that the IgG-Leptin is more
stable and has greater efficacy in vitro, in vivo it is less potent
than native Leptin, suggesting that approximately one-half of
the effects of Leptin to reduce food intake and body weight are
mediated by actions in front of the BBB while a complete
response requires transport across the BBB. To confirm this
notion, we measured the effects of native Leptin and IgG-Leptin
after administering them directly into brains of ob/obmice via an
osmotic infusion pump. As predicted, both native Leptin and
IgG-Leptin had equivalent effects in reducing food intake and
body weight (Figure 5C right panel). Consistent with prior re-
ports, neither native Leptin nor IgG-Leptin reduced food intake
or body weight in diet-induced-obese (DIO) mice (Figure S4,
left) or db/dbmice (Figure S4, right), thus excluding the possibil-
ity that the anorectic and weight-reducing effect of IgG-Leptin
might be due to non-specific effects.
DISCUSSION
Here we provide evidence that proteins can fold normally and
retain bioactivity when embedded within an antibody host, pro-
vided that suitable N- and C-terminal junctions to the protein
are found. Although the loops of antibodies are designed to allow
significant sequence variation, our experiments and those of
others show that not all, indeed few, sequences are transferable
directly (Jones et al., 1986). While the modified immunoglob-
ulin appears to retain its normal structure, we do note that our
autocrine selections are in some ways similar to the real-time
evolution of functional antibody molecules after the repertoire
is exposed to antigen, in that changes in the antibody CDRs
are selected for function.
The ability to embed a functional protein in an antibody could
depend on at least two key features of the system. The first is that
the binding energy of the four helices of Leptin or the a and b sub-
units of FSH for each other is high enough to overcome any
distortion caused by the insertion of defined junction sequences.
The other is that while permissive junctions are rare, the use of an
autocrine method for selecting suitable junctions was powerful
enough to yield junctions that were compatible with the proper
folding and integration of the guest molecules. Further studies
will reveal whether similar or different junction sequences are
required for the retention of bioactivity of other agonists inserted1143, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1139
Figure 5. IgG-Leptin Regulates Metabolism
In Vivo
(A) IgG-Leptin is stable at body temperature with
increased half-life in circulation. (Upper) Leptin or
IgG-Leptin was loaded into osmotic pumps, which
were implanted subcutaneously. The concentra-
tion of Leptin and IgG-Leptin inside of the pumps
was measured by ELISA at 3 days after the im-
plantation. (Lower) A single dose of Leptin or IgG-
Leptin was administered via the jugular vein, and
protein concentration in plasma was determined
through orbital bleeding at various time points.
(B) IgG-Leptin activates STAT3 in the hypo-
thalamus. Leptin or IgG-Leptin was administered
peripherally or centrally, and neuronal activation of
STAT3 in the hypothalamus was examined by
immunohistochemistry. Magnification, 103.
(C) IgG-Leptin exerts a metabolic function in vivo.
Leptin or IgG-Leptin was administered peripherally
into ob/ob mice (left), peripherally into wild-type
mice (middle), or centrally into ob/ob mice (right).
Body weight and food intake were recorded at
indicated time points before and after the treat-
ment. Body fat composition was measured at
beginning and end points of treatment.
All data are plotted as means ± SEM (error bars).into the antibody host using the method we have developed.
While one cannot easily deconvolute the contribution of each
parameter needed for bioactive incorporation of an agonist,
the fact that only a very small percentage of the junctional com-
binations were allowed strongly suggests that the binding energy
of the guest secondary structures for each other was not suffi-
cient to overcome the presence of non-permissive junctions. In
a certain sense, the junctions that are non-permissive are as
interesting as those that are. The main question is where does
the problem with non-permissive junctions arise? We speculate
that themain difficulty occurs during the folding of the host-guest
complex because non-permissive junctions do not allow either
the host, the inserted guests, or both to properly fold. To deter-
mine the advantage gained by using the random three-residue
linker in combination with the GGGGS linker, we compared the
efficacy of the simple glycine-serine linker to one where it is con-
nected to the random three-residue linker at both the N and
C termini. In the Leptin system, absence of the random three-
residue linker greatly decreased the activity of the most active
clone (Figure S5A). To ensure that the process of selection was1140 Chemistry & Biology 22, 1134–1143, August 20, 2015 ª2015 Elsevier Ltd All rights reseimportant, we also randomly picked 15
clones from the original libraries and
tested the activity of these clones using
an in vitro FRET assay. None of these un-
selected clones showed activity that was
comparable with the most active selected
clone, again emphasizing the importance
of the process of selection (Figures S5B
and S5C). The sequences of these non-
functional clones are shown in Tables S3
and S4.
Furthermore, the successful construc-
tion of host-guest complex also dependson the position in the host chosen for substitution. The key issue
concerns choosing a position in the protein where substitution is
allowed. Thus, we carried out a comprehensive study by
substituting a randomized four-residue peptide at five different
positions in the most active antibody clone that contained
embedded Leptin. In this case the embedded Leptin serves as
a probe to monitor protein folding. Here, no linker at the N or C
terminus of the substituted segments was used. The DNA frag-
ments coding the randomized four-residue peptides were de-
signed using the NNK codon strategy (N = A/C/G/T, K = G/T),
and overlapped with the antibody scaffold that contained
embedded Leptin. Substitutions were made at segments H6–
H9 (A), H23–H26 (B), H36–H39 (C), H47–H50 (D), and H64–H67
(E) (Kabat numbering [Kabat et al., 1991]) (Figure S6A). Lentivi-
ruses of these five libraries were produced and LepR SIE-Bla
cells were infected. Autocrine-based flow cytometry sorting
was carried out (Figures S6B and S6C). Compared with a
0.50% positive population in negative control (no infection) and
32% in the positive control (infected with lentivirus containing
the most active previously selected clone), the positiverved
population was 4.22%, 18.91%, 1.43%, 1.43%, and 2.22% in li-
braries for segments A, B, C, D, and E, respectively. This result
showed significant difference in terms of tolerance of substitu-
tion at different antibody regions. Segment B showed the highest
tolerance of substitution, which is consistent with the fact that it
is structurally adjacent to CDRH1. Other segments also showed
different levels of tolerance of substitution, shedding light on po-
tential positions where one can insert functional guests into the
antibody scaffold.
Our study demonstrates that when properly incorporated
into the antibody host, Leptin can retain its biological function.
Indeed, the fact that IgG-Leptin exhibits an enhanced potency
for downstream signaling in vitro confirms that the method is
robust and, together with the scFSH data, suggests that our
method for selecting functional junctions can be used for other
agonists. Recent evidence has shown that Leptin can act directly
on dendrites from neurons that project to the median eminence
(a CVO) and that it can also enter the median nucleus through
capillary fenestrations. After entering themedian eminence, Lep-
tin is taken up by tanycytes and transported into the ventricles,
and enters the brain parenchyma from the ventricular system
and in turn activates other brain regions (Balland et al., 2014).
We found that while IgG-Leptin activated STAT3 normally in
brain and had full bioactivity when administered i.c.v., it only
activated arcuate neurons in proximity to the median eminence
and had 50% reduction of bioactivity when administered
peripherally. This was despite the fact the IgG-Leptin was
more stable and had a lower EC50 than native Leptin. Although
the current version of IgG-Leptin showed a reduced ability to
cross the BBB, its BBB transport could possibly be enhanced
by further modifying the antibody structure. For instance, it has
recently been shown that a bispecific antibody that binds with
low affinity to the transferrin receptor, but with high affinity to
the target, efficiently penetrates the BBB through transcytosis
(Yu et al., 2011).
Overall, the generation of IgG-Leptin enabled us to establish
that full activity of Leptin requires BBB transport and that activa-
tion of ARC neurons that project dendrites to CVOs accounts for
half of the effect of Leptin on food intake and body weight. Leptin
also regulates of thermogenesis, immunity, and reproductive
function. Thus, this approach will allow us to assess the effects
of peripherally versus centrally administered IgG-Leptin on these
other physiologic readouts.
Since the antibody molecule has six loops, the system we
have developed may also have the potential for approximating
a variety of secondary structure elements in a relatively confined
three-dimensional space. While their functional synergy may be
rare, the power of autocrine-based phenotypic screens may be
sufficient to isolate those rare molecules where the guests oper-
ate in concert. Moreover, if only one antibody loop is used for the
guest, it may be possible to isolate molecules in which the bind-
ing function of the antibody is preserved so that the appended
new functionality can be targeted to only certain cells.
Finally, our experimental approach should complement the
ongoing theoretical studies of protein folding in a number of
ways (Xie et al., 2013; Yea et al., 2013; Zhang et al., 2012; Zhang
et al., 2013a). First, since current theoretical studies investi-
gate the database of natural proteins, they uncover what has
happened in evolution, whereas we can define the universe ofChemistry & Biology 22, 1134–elements that can work rather than only those that have worked.
Second, discovery of new permissive junctions can give addi-
tional data points for refinement of theoretical and computational
studies on the nature of junctions in proteins. These approaches,
if successful, could be extended to the general problem of
protein folding whereby one could study which new sequences
inserted anywhere in a protein allow the folding pathway to pro-
ceed along the natural or even a new route. Finally, the identifica-
tion of junction sequences that preserve function could have
practical implications insofar as there are potential pharmacoki-
netic and functional benefits of generating recombinant proteins
that do not have an exposed amino or C terminus.
SIGNIFICANCE
We describe here a powerful selection system for insert-
ing functional proteins into other proteins. This system is
different from previous work in that instead of being design
based, it is high-throughput selection based. This method
should be useful for constructing new proteins and as a
tool to help solve the problem of protein folding.
EXPERIMENTAL PROCEDURES
Reagents
Rabbit anti-phospho-STAT3 was from Cell Signaling. Human Leptin ELISA
kit was from R&D Systems. Mouse recombinant Leptin was from Amgen.
Osmotic pumps and brain infusion kits were from Alzet.
Construction of Combinatorial Antibody Libraries
BamHI and XmaI restriction sites were introduced into the CDR H3 loop in the
scaffold. Leptin was amplified with combination of three forward primers (LF1,
LF2, LF3) and three reverse primers (LR1, LR2, LR3) (Table S5) and cloned into
the scaffold using BamHI and XmaI. scFSHwas constructed by linking the 30 of
a gene encoding the b chain and the 50 of gene encoding the a chain with
GGATCAGGATCGAACGCGACGGGGTCAGGTTCTAATGCAACTTCAGGATC
GACTAGT. Then scFSH was amplified using a strategy similar to that used for
the Leptin constructs (Table S6).
Construction of Stable Cell Lines
The human LepR gene fused with C-terminal hemagglutinin epitope (HA) tag
was cloned into the pLV2-based vector in which the expression of the gene
of interest was driven by the elongation factor 1a promoter. The CellSensor
SIE-Bla HEK293T cells were transduced and stimulated with 1 ng/ml recombi-
nant human Leptin protein (R&D Systems). Leptin-responsive cells were
sorted using the LiveBLAzer-FRET B/G Loading Kit (Life Technology) with an
excitation wavelength of 409 nm and emission wavelengths of 460 nm and
530 nm.
Construction of the human FSHR cell line followed the same strategy as
for the human LepR, except that cells were co-transduced with lentiviruses
expressing b-lactamase controlled by CRE.
To construct the Baf3 LepR cell line, the human LepR was cloned into
pMSCVpuro vector, which was then transfected into Phoenix cells to generate
retrovirus. Interleukin-3-dependent Baf3 cells were infected with the retrovirus
and cells were selected with 10 mg/ml puromycin. The puromycin-resistant
cells were subsequently cultured in media containing 10 ng/ml Leptin.
Autocrine-Based Cell Sorting
LepR SIE-Bla and FSHR CRE-Bla cells were transduced with the correspond-
ing lentiviral combinatorial junction libraries at an MOI of approximately 2.
Lentiviruses were removed 5 hr after infection, and methylcellulose media
was placed on top of cells to limit diffusion of secreted antibodies to neigh-
boring cells. Twenty hours after lentivirus infection, the methylcellulose media
were washed away with media and cells were trypsinized, loaded with1143, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1141
LiveBLAzer-FRET B/G substrate, incubated at room temperature for 2 hr with
agitation, washed with FACS buffer, and sorted with a MoFlo Astrios sorter.
Positive cells were gated based on the highest ratio of fluorescence in the
Pacific Blue channel to that in the AmCyan channel.
Animal Procedures
All surgical procedures in mice were performed in compliance with the proto-
cols approved by the Institutional Animal Care and Use Committee of Rock-
efeller University. Wild-type C57Bl6/J, ob/ob, db/db, and DIO mice were
from the Jackson Laboratory.
To characterize their in vivo function by peripheral administration, proteins
were delivered via osmotic pumps implanted subcutaneously, at 600 ng/hr
for mouse Leptin, 3,600 ng/hr for IgG-Leptin, or 2,920 ng/hr for scaffold con-
trol. For central administration, proteins were delivered to lateral ventricle via
osmotic brain infusion pumps, at 50 ng/hr for Leptin and 300 ng/hr for IgG-
Leptin. Food intake and body weight for each mouse were measured daily
during indicated experimental periods. Fat composition was measured using
an EchoMRI Body Composition Analyzer.
To determine the rate of protein clearance, a single dose of Leptin (4.5 mg) or
IgG-Leptin (27 mg) was delivered into mice via the jugular vein, and blood was
then collected at indicated time points. The plasma concentration of mouse
and human Leptin was measured using Mouse/Rat Leptin Quantikine ELISA
Kit (R&D Systems) and Human Leptin Quantikine ELISA Kit (R&D Systems),
respectively.
To examine neuronal activation in vivo, ob/obmice were treated with Leptin
(2.5 mg/g body weight) or IgG-Leptin (15 mg/g body weight) via intraperitoneal
injection, or with Leptin (100 ng) or IgG-Leptin (600 ng) via i.c.v. injection. One
hour after the treatment, mice were transcardially perfused with PBS followed
by 4% paraformaldehyde. Brain samples were then dissected, post-fixed with
4% in the hypothalamus and determined by free-floating immunostaining as
previously described (Knight et al., 2010).
The methods of cell culture, production of lentiviruses, proliferation assay,
CD spectroscopy measurement, differential HDX-MS, and peptide identifica-
tion and HDX data processing are detailed in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes the structure and dynamics of the Leptin
host-guest construct, Supplemental Experimental Procedures, six figures,
and six tables and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2015.07.011.
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